Over twenty years ago, Dr. Ronald Hunninghake and Dr. Hugh Riordan joined together to conduct a research on I.V. administration of vitamin C for cancer patients. This was an inspiration to many others who eventually did similar researches.
Based on prior work of Dr. Hunninghake, a new study shows that vitamin C kills colorectal cancer cells. Namely, it was found that the equivalency of vitamin C found in 300 oranges was found to kill colorectal cancer cells. This type of cancer is the third most common cancer in the United States and nearly half of the cases are more aggressive and do not respond to conventional therapies.
According to a study from Weill Cornell Medicine in New York, high-dose vitamin C caused oxidation in the cancer cells and impaired the growth of the tumors.
These findings can also contribute in treating renal cell carcinoma, bladder cancer and pancreatic cancer. The authors of the study report that that dosage would most likely need to be through I.V. as oral doses are not absorbed efficiently enough through the intestine.
According to Dr. Hunninghake, an average person should take 1 gram of vitamin C twice per day. If you are suffering from chronic infections or fatigue you can gradually increase the does to a bowel tolerance dose. Also, if you are fighting a serious illness, Dr. Hunninghake recommends I.V. vitamin C therapy. If you are battling cancer or another chronic disease, consider intravenous vitamin C therapy.
Many people eat oranges as a vitamin C source, but red and yellow bell peppers have the highest vitamin C coming in at 306 percent of daily value. Other fruits and vegetables are guavas, dark leafy greens, kiwi, broccoli, berries, tomatoes, peas, papaya, and of course oranges.